by eLife A new tool using cutting-edge technology is able to distinguish different types of blood clots based on what caused them, according to a study published in eLife. The tool could help physicians diagnose what caused a blood clot and help them select a treatment that targets cause to break it up. For example,...
Polycystic hepatorenal diseases are hereditary genetic disorders characterized by the progressive development of multiple symptomatic cysts in the kidneys and/or liver that may cause alterations in the function of those organs and/or complications associated with their growth. Right now, there are no effective pharmacological treatments and the only curative option is organ transplant. Researchers at...
by Lund University Can a very common allergy medicine improve survival among patients suffering from the serious skin cancer, malignant melanoma? A new study from Lund University in Sweden indicates that this may be the case. “Previous studies have shown that the same antihistamines have survival benefits in breast cancer. Now we see the same...
by Hong Kong Baptist University A research team led by Hong Kong Baptist University (HKBU) has developed a novel anti-Epstein-Barr virus (EBV) drug that can selectively disrupt a viral protein produced by EBV, leading to the shrinkage of tumors caused by the virus. It is the first known agent to successfully target the virus and...
A nasal spray derived from algae and a plant in the tobacco family could offer a preventive measure for COVID-19, according to a new study. Researchers are making a molecule called Q-griffithsin using an anti-viral protein found in the New Zealand red algae Griffithsia and Nicotiana benthamiana, a plant in the same family as tobacco...
by Perelman School of Medicine at the University of Pennsylvania When Castleman Disease patients have a flare of their symptoms, they experience a cytokine storm inside their bodies—a hyper-response from the immune system that can cause a fever, organ failure, and even death. Now researchers at the Perelman School of Medicine at the University of...
by Bob Yirka , Medical Xpress RUVBL2 protein (in red) acts to integrate the circadian repressive super-complex, and how the physiological metabolite of cordycepin (CoTP, the green key) breaks down the complex and causes a 12-hour clock phase-shift. Credit: Zhancong Xu A team of researchers from several institutions in China and two in the U.S....
CINCINNATI – After 20 years of trying, modern medicine remains unable to lower the roughly 40 percent mortality rate for the severe childhood immune disease called HLH (hemophagocytic lymphohistiocytosis), which damages vital organs and tissues. Now, researchers report in the New England Journal of Medicine treating patients with a new drug that saved kid’s lives...
May 4, 2020 — A study at Columbia University Mailman School of Public Health found that long-term buprenorphine treatment is associated with improvements in health care outcomes. Compared to individuals who discontinued buprenorphine, those with continuous treatment had significantly lower rates of prescription opioid use and opioid-related events, including medically treated overdoses in the follow-up...
by European Space Agency Radiologists are investigating people’s medical conditions and pregnancies remotely thanks to an ESA-backed robotic technology. The set-up enables medics to care for some patients at a distance during the coronavirus pandemic. The system is already being used by rural hospitals, care homes and prisons across Europe and in Canada to investigate...
